title: Fibrotic encapsulation of a dexamethasone intravitreal implant following vitrectomy and silicone oil for rhegmatogenous retinal detachment.
abstract: Steroids are commonly used as adjunct therapy in the management of proliferative vitreoretinopathy. The authors report a case of proliferative vitreoretinopathy treated with an intravitreal dexamethasone implant following vitrectomy in a silicone oil-filled eye. Epiretinal fibrosis developed around the implant at 6 weeks postoperatively, resulting in a recurrent retinal detachment. This was repaired by vitrectomy, removal of the implant, and peeling of epiretinal proliferation.
authors.forename: Sophie J
authors.initials: SJ
authors.lastname: Bakri
authors.forename: Saba T
authors.initials: ST
authors.lastname: Alniemi
mesh_terms: D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage*; D004343:Drug Implants; D058450:Endotamponade; D005355:Fibrosis; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D012160:Retina / Q000473:pathology*; D012163:Retinal Detachment / Q000601:surgery*; D012827:Silicone Oils / Q000008:administration & dosage*; D041623:Tomography, Optical Coherence; D014821:Vitrectomy; D018630:Vitreoretinopathy, Proliferative / Q000628:therapy*
chemical_list: D004343:Drug Implants; D005938:Glucocorticoids; D012827:Silicone Oils; D003907:Dexamethasone